Molecular Sciences V. Lectures
Dr. Pajtók, Csenge
Semmelweis Egyetem, I. sz. Gyermekgyógyászati Klinika
+36306543170
pajtok.csenge@gmail.com
New Therapeutic Opportunity in the Treatment of Ischemia-Reperfusion Induced Acute Renal Failure
Csenge Pajtók1, Domonkos Pap2, Beáta Szebeni2, Apor Veres-Székely1, István M. Takács1, Eszter Lévai1, Katalin Adrienna Kékesi3, Gábor Juhász4, Attila J. Szabó1,2, Ádám Vannay 1,2
1 1st Department of Paediatrics, Semmelweis University, Budapest
2 MTA-SE Pediatrics and Nephrology Research Group, Budapest
3 Laboratory of Proteomics, Institute of Biology, Eötvös Loránd University, Budapest
4 Department of Anatomy, Cell and Developmental Biology, Eötvös Loránd University, Budapest
Molecular Sciences V. Lectures
English
Molecular Sciences
Clinical Medicine
Introduction: Acute renal failure (ARF) has a high risk of morbidity and mortality without reliable therapeutic intervention. The most common cause of ARF is renal ischemia reperfusion (I/R) injury, which may associated with various clinical situations including major surgery, cardiac arrest or organ transplantation.
Aim: Our aim was to better understand the pathomechanism of renal I/R injury find new biomarkers or therapeutic targets.
Methods: Two-dimensional gel electrophoresis and proteomic evaluation was carried out on rat kidneys following I/R injury. The significantly changed proteins were analyzed by bioinformatics approaches. The role of Parkinson’s diseases 7 (PARK7) in oxidative stress (H2O2) induced cell death was investigeted by its overexpression or pharmacological modulation in the HEK-293 kidney epithelial cells. We also examined the effect of the modulation of PARK7 in I/R induced mice models of ARF in vivo.
Results: PARK7 was identified as central factor related to I/R induced oxidative stress in the kidney. PARK7 overexpression and its pharmacological modulation decreased H2O2 induced apoptosis of HEK-293 cells. Accordingly, pharmacological modulation of PARK7 improved renal function in mice following I/R induced ARF.
Conclusion: Our data suggest that PARK7 plays a role in the reduction of renal I/R injury associated oxidative damage probably through activation of antioxidant or anti-apoptotic mechanisms. Therefore, PARK7 may serve as therapeutic target in the treatment of I/R injury induced ARF.
Grant support: This paper was supported by 20382-3/2018 FEKUTSTRAT grants and Semmelweis Science and Innovation Fund.
Supervisor: Domonkos Pap
e-mail address: pap.doma@gmail.com
Szóbeli
Szabad
elfogadva
szóbeli
nem rendelkezett róla
4740
16:30
16:45
Csenge Pajtók1, Domonkos Pap2, Beáta Szebeni2, Apor Veres-Székely1, István M. Takács1, Eszter Lévai1, Katalin Adrienna Kékesi3, Gábor Juhász4, Attila J. Szabó1,2, Ádám Vannay 1,2
1 1st Department of Paediatrics, Semmelweis University, Budapest
2 MTA-SE Pediatrics and Nephrology Research Group, Budapest
3 Laboratory of Proteomics, Institute of Biology, Eötvös Loránd University, Budapest
4 Department of Anatomy, Cell and Developmental Biology, Eötvös Loránd University, Budapest